Clinical Trials Browser

Phase 2 × Interventional × Autoimmune Diseases × Clear all

NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Phase 2 Active not recruiting

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

NCT06817889 2026-02-27

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Phase 2 Recruiting

Autoimmune Diseases, Respiratory Syncytial Virus Infections

NCT03922724 2025-12-31

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Phase 2 Recruiting

Autoimmune Diseases, Immune System Diseases, Lymphoproliferative Disorders, Opportunistic Infections, Lymphoma, T-Cell, Peripheral

NCT01545518 2014-09-01

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Phase 2 Terminated

20 enrolled 3 charts

Drug Resistant Epilepsy, Autoimmune Diseases, Epilepsy, Epilepsies, Partial, Autoimmune Diseases of the Nervous System, Limbic Encephalitis

NCT00466843 2009-06-02

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Autoimmune Diseases, Leukemia, Myelodysplastic Syndromes